Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | 890.57M | 898.91M | 845.52M | 783.58M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 890.57M | 898.91M | 845.52M | 783.58M | |
| Cost of Revenue | 473.26M | 530.01M | 454.31M | 408.63M | |
| Gross Profit | 417.31M | 368.90M | 391.21M | 374.95M | |
| SG&A Expenses | 189.93M | 199.76M | 189.53M | 175.22M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | 7.21M | -22.70M | 18.84M | 9.79M | |
| Total Operating Expenses | 711.46M | 743.97M | 699.12M | 634.88M | |
| Operating Income | 179.11M | 154.94M | 146.41M | 148.70M | |
| Income Before Tax | 147.25M | 90.45M | 104.98M | 121.44M | |
| Income Tax Expenses | 38.27M | 35.50M | 27.24M | 31.57M | |
| Earnings from Continuing Operations | 108.98M | 54.95M | 77.74M | 89.87M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -814.20K | 116.40K | -- | 210.50K | |
| Net Income | 108.17M | 55.06M | 77.74M | 90.08M | |
| EBIT | 179.11M | 154.94M | 146.41M | 148.70M | |
| EBITDA | 271.46M | 161.69M | 234.82M | 230.15M | |
| EPS Basic | 1.12 | 0.57 | 0.79 | 0.93 | |
| Normalized Basic EPS | 0.94 | 0.68 | 0.67 | -- | |
| EPS Diluted | 1.12 | 0.57 | 0.79 | 0.93 | |
| Normalized Diluted EPS | 0.94 | 0.68 | 0.67 | -- | |
| Average Basic Shares Outstanding | 96.88M | 96.82M | 97.86M | 97.27M | |
| Average Diluted Shares Outstanding | 96.88M | 96.82M | 97.86M | 97.27M | |
| Dividend Per Share | -- | 0.80 | -- | -- | |
| Payout Ratio | 72.15% | 0.00% | 97.96% | -- | |